Orbit Discovery awarded Innovate UK grant to expand high throughput cell-based functional screening platform capabilities in peptide drug discovery
Orbit Discovery Ltd., (“Orbit”) a privately held biopharmaceutical company focused on discovering candidate peptide therapeutics harnessing proprietary affinity and cell-based functional screening platforms, has been awarded a Smart grant by Innovate UK, the UK’s innovation agency.
United Kingdom Laura Thomson Orbit Discovery Ltd From Orbit Discoveryjun Discovery Ltd Innovate United Kingdom
Source: news-medical.net